Human protease-activated receptor-1 and 4 (PAR-1 and PAR-4) expression in stage I non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Selvaggi, G [1 ]
Ghio, P [1 ]
Novello, S [1 ]
Cappia, S [1 ]
Papotti, M [1 ]
Lausi, P [1 ]
Borasio, P [1 ]
Scagliotti, GV [1 ]
机构：
[1] Univ Turin, Pathol Serv, Orbassano, TO, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7160
引用
收藏
页码：656S / 656S
页数：1
相关论文
共 50 条
  • [21] Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    Katayama, Kanji
    Yamaguchi, Akio
    [J]. ANTICANCER RESEARCH, 2008, 28 (2A) : 847 - 854
  • [22] Receptor binding and agonist efficacy: New insights from mutants of the thrombin protease-activated receptor-1 (PAR-1)
    Hollenberg, MD
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (06) : 1175 - 1177
  • [23] Activation of protease-activated receptor-1 (PAR-1) inhibits neurally evoked chloride secretion in the mouse colon
    Buresi, MC
    Vergnolle, N
    Andrade-Gordon, P
    Hollenberg, MD
    Wallace, JL
    Macnaughton, WK
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A23 - A23
  • [24] IN VIVO PROTEASE-ACTIVATED RECEPTOR-1 MEDIATED CORONARY VASOREACTIVITY CORRELATES WITH PAR-1 EXPRESSION DISTRIBUTION IN THE CORONARY VASCULAR WALL
    Kasasbeh, E. S.
    Phillips, S. A.
    Couhtino, L.
    Williams, P.
    Nunnally, A. H.
    Adcock, J.
    Wang, L.
    Hamm, H. E.
    Cleator, J. H.
    [J]. CARDIOLOGY, 2015, 131 : 285 - 285
  • [25] Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
    Duvernay, Matthew
    Young, Summer
    Gailani, David
    Schoenecker, Jonathan
    Hamm, Heidi
    [J]. MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 781 - 792
  • [26] ANGIOGENESIS IN STAGE I NON-SMALL-CELL LUNG CANCER (NSCLC): EXPRESSION OF HUMAN PROTEASE-ACTIVATED RECEPTORS (PARS)
    Ghio, P.
    Selvaggi, G.
    Novello, S.
    Cappia, S.
    Papotti, M.
    Giorio, S.
    Caggese, D.
    Borasio, P.
    Lausi, P.
    Scagliotti, G. V.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 39 - 39
  • [27] Protease-activated receptor(PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma
    Si-Man LI
    Ping JIANG
    Yang XIANG
    Wei-Wei WANG
    Yue-Chun ZHU
    Wei-Yang FENG
    Shu-De LI
    Guo-Yu YU
    [J]. Zoological Research, 2014, 35 (05) : 420 - 425
  • [28] Protease-activated receptor-4 (PAR-4) is a novel mediator of vascular remodeling in diabetes
    Pavic, G.
    Rauch, B. H.
    Fischer, J. W.
    Schroer, K.
    Fender, A. C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S61 - S61
  • [29] Effect of Protease-Activated Receptor-1 (PAR-1) Activating Peptide in Murine Model of Endotoxin-Induced Lung Injury.
    Tanaka, R.
    Goto, E.
    Tsumura, S.
    Kojima, K.
    Saeki, S.
    Ito, K.
    Saita, N.
    Kohrogi, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [30] Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1,-2, and-4) in prostate cancer
    Black, Peter C.
    Mize, Gregory J.
    Karlin, Peter
    Greenberg, Daniel L.
    Hawley, Sarah J.
    True, Lawrence D.
    Vessella, Robert L.
    Takayama, Thomas K.
    [J]. PROSTATE, 2007, 67 (07): : 743 - 756
12345